Pablo Ruda Vega, MD
Biography
- Director, Cardiac Surgery, UH Lake Health
- Director, Cardiac Surgery Network, UH Cleveland Medical Center
Pablo Ruda Vega, MD, is a cardiac surgeon with University Hospitals Harrington Heart & Vascular Institute.
Dr. Ruda Vega earned his medical degree from the University of Buenos Aires, then completed two residencies, in general surgery and cardiovascular surgery, at the Italian Hospital of Buenos Aires in Argentina. Dr. Ruda Vega then came to the United States to complete a residency and fellowship in adult cardiac surgery at the Cleveland Clinic.
After his training, Dr. Ruda Vega returned to Argentina where he worked as a staff surgeon, eventually earning the role of chairman of cardiac surgery for the San Jose and San Cayetano clinics in Buenos Aires. He was then recruited to University Hospitals Harrington Heart & Vascular Institute in 2021.
In addition to his large surgical practice, Dr. Ruda Vega excels as an educator, serving as lecturer, instructor or lead administrator for multiple professional conferences. He has also authored more than 100 peer-reviewed publications, abstracts and book chapters on various topics related to cardiac surgery advances and techniques.
Languages Spoken
English, Spanish
Office Locations
UH Minoff Health Center at Chagrin Highlands
3909 Orange Pl
Beachwood OH, 44122
216-844-3800
Education
Fellowship | Cardiac Surgery
Cardiac Surgery - Cleveland Clinic (2001 - 2003)
Residency | Cardiovascular Surgery
Cardiovascular Surgery - Hospital Italiano De Buenos Aires (1997 - 2001)
Residency | General Surgery
General Surgery - Hospital Italiano De Buenos Aires (1993 - 1997)
Medical Education
Universidad De Buenos Aires, Facultad De Ciencias Medicas (1993)
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Pablo Ruda Vega did not disclose any Outside Relationships with Industry.